Simple Summary Endometrial cancer (EC) is the most common gynaecologic malignancy in
developed countries. Most patients are sufficiently treated with removal of uterus, tubes and …

Histopathological evaluation including subtyping and grading is the current cornerstone for
endometrial cancer (EC) classification. This provides clinicians with prognostic information …

Objective Categorization and risk stratification of endometrial carcinomas is inadequate;
histomorphologic assessment shows considerable interobserver variability, and risk of …

Purpose: Recommendations for adjuvant treatment for women with early-stage endometrial
carcinoma are based on clinicopathologic features. Comprehensive genomic …

Simple Summary The Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE)
is a recently developed tool to identify four distinct molecular subgroups of endometrial …

Endometrial cancer (EC) is one of the most common gynecological malignancies in Western
countries. Traditionally, loco-reginal dissemination and histological characteristics are the …

Molecular characterization of endometrial cancer into subgroups has prognostic and
therapeutic implications. Further development of an integrated molecular risk profile may …

Background: Classification of endometrial carcinomas (ECs) by morphologic features is
inconsistent, and yields limited prognostic and predictive information. A new system for …

Although endometrial carcinoma (EC) is generally considered to have a good prognosis,
over 20% of women with EC die of their disease, with a projected increase in both incidence …

Endometrial cancer (EC) is the sixth most common cancer in women worldwide and its
mortality is directly associated with the presence of poor prognostic factors driving tumor …